They more and more drew negative focus. "There is no doubt we've missing a considerable number of business enterprise for this reason substitution on the trade name for the generic name," Elliot Fisher, attorney for Lemmon, who made the drug, advised Affiliated Push in 1981.The us federal government set in loads of exertion to eradicate the drug an